Subscribe To
arbutus to report third quarter 2023 financial results and provide corporate update
WARMINSTER, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- arbutus Biopharma Corporation (Nasdaq: ABUS) (“
October 24, 2023, 7:30 am
arbutus announces multiple abstracts accepted for presentation at aasld – the liver meeting® 2023
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) — ...
October 11, 2023, 12:05 pm
arbutus (abus) to focus on hepatitis b candidates, stock up
arbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies wh...
September 12, 2023, 10:36 am
arbutus biopharma (abus) reports q2 loss, lags revenue estimates
arbutus Biopharma (ABUS) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus E...
August 3, 2023, 10:31 am
Are medical stocks lagging amphastar pharmaceuticals (amph) this year?
Here is how Amphastar Pharmaceuticals (AMPH) and arbutus Biopharma (ABUS) have performed compared to th...
June 23, 2023, 11:09 am
arbutus presents preliminary ab-729 and pegylated interferon alfa-2a combination data at the easl congress 2023
Treatment was generally well tolerated with continued HBsAg declines in some patients WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE) — ...
June 21, 2023, 6:01 am
Is amphastar pharmaceuticals (amph) stock outpacing its medical peers this year?
Here is how Amphastar Pharmaceuticals (AMPH) and arbutus Biopharma (ABUS) have performed compared to th...
June 7, 2023, 10:48 am
arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — arbutus Biopharma Corporation (Nasdaq: ABUS), a cli...
June 7, 2023, 6:01 am
arbutus to present ab-729 and ab-836 data at easl congress 2023
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- arbutus Biopharma Corporation (Nasdaq: ABUS), a clin...
June 7, 2023, 2:01 am
arbutus to present at jefferies healthcare conference
WARMINSTER, Pa., May 31, 2023 (GLOBE NEWSWIRE) — arbutus Biopharma Corporation (Nasdaq: ABUS) (“
May 31, 2023, 11:30 am
Is amphastar pharmaceuticals (amph) outperforming other medical stocks this year?
Here is how Amphastar Pharmaceuticals (AMPH) and arbutus Biopharma (ABUS) have performed compared to th...
May 22, 2023, 11:20 am
arbutus (abus) upgraded to buy: here's why
arbutus (ABUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the compan...
May 9, 2023, 1:45 pm
arbutus to present at jmp securities life sciences conference
WARMINSTER, Pa., May 09, 2023 (GLOBE NEWSWIRE) — arbutus Biopharma Corporation (Nasdaq: ABUS) (“
May 9, 2023, 11:30 am
Is arbutus biopharma (abus) outperforming other medical stocks this year?
Here is how arbutus Biopharma (ABUS) and Hologic (HOLX) have performed compared to their sector so far ...
May 4, 2023, 11:27 am
arbutus biopharma (abus) reports q1 loss, tops revenue estimates
arbutus Biopharma (ABUS) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus E...
May 4, 2023, 10:41 am
arbutus provides ab-729 clinical data and ab-161 preclinical data as oral presentations at the global hepatitis summit 2023
Seven patients with cHBV remain off all treatment and continue to maintain low levels of HBV DNA and HBsAg for at least one and half years post- AB-72...
April 27, 2023, 7:20 am
arbutus biopharma clinical hold slows hepatitis b momentum: broker
Analysts at Baird Equity Research have awarded arbutus Biopharma a ‘Neutral' rating after the early-s...
April 26, 2023, 2:44 pm
arbutus announces fda clinical hold on ind application for ab-101, an oral pd-l1 inhibitor
WARMINSTER, Pa., April 25, 2023 (GLOBE NEWSWIRE) — arbutus Biopharma Corporation (Nasdaq: ABUS) (“<...
April 25, 2023, 11:30 am
arbutus to participate in three upcoming investor conferences
WARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- arbutus Biopharma Corporation (Nasdaq: ABUS), a clin...
February 6, 2023, 7:30 am
arbutus biopharma corporation (abus) q3 2022 earnings call transcript
arbutus Biopharma Corporation (NASDAQ:ABUS ) Q3 2022 Earnings Conference Call January 1, 2022 8:45 AM E...
November 9, 2022, 10:42 am